Related Experiment Video
Updated: Aug 24, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors
Bharat B Aggarwal1, Uddalak Bhardwaj, Yasunari Takada
1Cytokine Research Section, Department of Bioimmunotherapy, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
The discovery of an agent that selectively kills tumor cells and not normal cells is the dream of every cancer researcher. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), first discovered in 1995, was heralded as a selective killer of tumor cells, and its potential is still thought to be high. Almost immediately, broad efforts were made to understand its activity at the molecular level. TRAIL has been shown to interact with the cell surface through five distinct receptors, named death receptor (DR) 4, DR5, decoy receptor (Dc)R1, DcR2, and osteoprotegrin. It activates nuclear factor (NF)-kappaB, c-Jun N-terminal kinases, and apoptosis. The apoptotic signals are mediated through Fas-associated death domain protein (FADD)-mediated recruitment of caspase-8 and caspase-3. Additionally, caspase-8 can cleave Bcl-2 homology domain 3 (BH3)-interfering domain death agonist (Bid), and the cleaved Bid then causes the release of mitochondrial cytochrome c, leading to the activation of pro-caspase-9, which can then activate pro-caspase-3. TRAIL-induced apoptosis is negatively regulated by numerous cellular factors including decoy receptors, cellular FADD-like interleukin 1 beta-converting enzyme (FLICE) interacting protein (cFLIP), cellular inhibitor of apoptosis protein (cIAP), X-linked IAP (XIAP), survivin, and NF-kappaB. Second mitochondria-derived activator of caspases (Smac)?direct IAP binding protein with low pI (DIABLO) mediates proapoptotic signals through inaction of IAP. How the TRAIL-induced apoptosis is downregulated by these factors is discussed in detail in this review. Whether TRAIL selectively kills tumor cells without harming normal cells is also discussed.
Insights
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) shows promise as a selective cancer therapy. This review details TRAIL
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was discovered in 1995.
- TRAIL was heralded as a selective tumor cell killer with high potential.
- Its molecular activity has been extensively studied.
Purpose of the Study:
- To review the molecular mechanisms of TRAIL-induced apoptosis.
- To discuss the cellular factors regulating TRAIL-induced apoptosis.
- To evaluate TRAIL's selectivity in killing tumor cells versus normal cells.
Main Methods:
- Interaction of TRAIL with five cell surface receptors (DR4, DR5, DcR1, DcR2, osteoprotegrin).
- Activation of apoptotic signaling pathways involving FADD, caspases, and mitochondria.
- Analysis of negative regulatory factors of TRAIL-induced apoptosis.
Main Results:
- TRAIL triggers apoptosis via caspase-8 and caspase-3 activation.
- Cleaved Bid leads to mitochondrial cytochrome c release and caspase-9 activation.
- Numerous cellular factors, including decoy receptors and IAPs, negatively regulate TRAIL-induced apoptosis.
Conclusions:
- TRAIL-induced apoptosis is a complex process regulated by multiple cellular factors.
- Understanding these regulatory mechanisms is crucial for optimizing TRAIL-based cancer therapies.
- The selectivity of TRAIL in killing tumor cells remains a key area of investigation.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Regulation of the Unfolded Protein Response
Caspases

